Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > 10%

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Jul 13, 2022 12:33pm

69 Views

Post# 34821160

RE:RE:RE:RE:10%

I never look at my mail b4 once I reach the golf course except today ...I played lousy

SPCEO1 wrote: You are right - I misread it as a zero interest loan when it is actually interest only for 2-3 years.

It should be obvious that a small company like TH is going to be classified as a junk borrower. That is no surprise.

Hope the golf game went well!

palinc2000 wrote: my first read is interest rate over 11% which indicates junk territory....

SPCEO1 wrote: The agreed interest rate is 0% for the first 2, possibly 3 years.

canadapiet wrote: They are paying more then 10% !!!!!
Ok,no dilution for now, but a lot of intrest to pay.
Positive that such an institution believes in their future.

So i rebought a piece of the shares i sold at 3,30 CAD.

GLA